Slide 1: Morgans Technology Conference
control bionics MoRGANs TECHNOLOGY CONFERENCE November 24 2021 Control Bionics Limited ABN 45 115 465 462 Morgans Technology Conference | November 24, 2021
Slide 2: Disclaimer
Disclaimer This presentation is intended to provide a general outline only and is not intended to be a definitive statement on the subject matter covered in it. The information in this presentation, whether written or verbal, has been prepared without taking into account the commercial, financial or
Slide 3: Where has the business come from?
WHERE HAS THE BUSINESS COME FROM? Inspired mind of our Founder and his ultimate vision to free the human inside, no matter how locked in, through wireless wearable technology connected to body. We are just beginning to understand what’s possible. “The totally wired user” Peter Ford Founder 3 Morgans
Slide 4: Mission
mission To be the global leader in innovative augmentative communications and control devices 4 Morgans Technology Conference | November 24, 2021
Slide 5: World class Australian wireless wearable EMG technology
WoRLD CLASS AUSTRALIAN Wireless Wearable EMG TECHNOLOGY • Leading EMG Technology • Spatial orientation technology • Low latency brain intent activation via EMG • 24hr battery • Non Invasive • Connects to speech generating software • Windows, iOS, Android • Allows locked in or compromised people to c
Slide 6: Creating market winning products
Creating Market WINNING ProdUCTS We combined our NeuroNode wearable technology with high quality eye-gaze camera technology creating market leading products that delivered faster communication speed and significantly less fatigue than existing competition globally. 6 Morgans Technology Conference |
Slide 7: Morgans Technology Conference | November 24, 2021
Morgans Technology Conference | November 24, 2021
Slide 8: Our Products
Our Products • World class patented NeuroNode technology • Two primary assistive communication technology solutions for disability sector globally 8 Morgans Technology Conference | November 24, 2021
Slide 9: Technology Roadmap
TECHNOLOGY ROADMAP 2022 2023 2024 2025 2030 9 Morgans Technology Conference | November 24, 2021
Slide 10: Global growth plan since IPO Dec 2020
GloBAL GROWTH PLAN SINCE IPO Dec 2020 • Strategic Priorities FY21 • Increased expansion in Australian assistive technology sector • Increased expansion in North America assistive technology sector • International expansion Japan & Singapore • Investment in R&D to enhance product range & miniaturise
Slide 11: Exciting, successful & challenging FY21
Exciting, SuCCESSFUL & Challenging FY21 • Revenue of $3.97m • Investment year with 28% YOY growth in revenue despite COVID-19 business impact • Solid growth in key regions of USA and Australia • Strong balance sheet with $12.3m in cash as at June 30th • Top 10 Financial Review Boss Most Innovative C
Slide 12: Make a life-changing connection
make a life–changing connection 12 Morgans Technology Conference | November 24, 2021
Slide 13: Momentum for the year ahead
MOMENTUM FOR the year ahead 13 Morgans Technology Conference | November 24, 2021
Slide 14: Significant addressable market
Significant Addressable Market (Current Focus) Type to enter a caption. 14 Morgans Technology Conference | November 24, 2021
Slide 15: Momentum with senior global management team
Momentum with Senior Global Management Team Rob Wong Neale Java Todd Tyler Annette Curry Peter Ford James Schorey CEO CFO Vice President Australia Region Director of Innovation CTO North America Sales Director – new markets Chris Feighner Stacey Berard Jamie Lemsing Meagan Koeneman Kristen Alex Alva
Slide 16: Key priorities 2021/22
Key Priorities 2021/22 • Revenue Growth • Revenue growth focus in Australia and North America through partners and sales team channels post COVID-19 • Operating Expenditure • Optimise productivity and strategic investments • Product leadership • NEW branding and marketing investment in awareness • N
Slide 17: Expanded Product Range FY22
Expanded Product Range FY22 ` Morgans Technology Conference | November 24, 2021 17
Slide 18: New Product - Australia Launch
New Product - Australia Launch • Compact handheld device speech generating software with detachable speaker, keyboard guides • Launched in Australia Q2, 2022 • Estimated there are 164,000 people in Australia with autism, 58% have communication disabilities, and 43,000 are registered with NDIS*. • Th
Slide 19: New Cosmos Connect Plug-in
NEW COSMOS CoNNECT PlUG-IN • Allows single switch users to connect to multiple components like XBOX game consoles, feeding robots, iOS devices, Android devices and toys. • Includes Pilot Mode so users can play with friends and family • Expected to be a strong sales add-on for core Control Bionics AA
Slide 20: Innovation Roadmap
innovation ROADMAP • Extension markets for NeuroNode IP & users. More control of environment and wheelchair transport. R&D partnership with Deakin University for wheelchair control. • Taps Global $5.4B (2027), CAGR 7.3%, power wheelchair market.* * marketwatch.com/press-release/electric-wheelchair-m
Slide 21: Innovation Roadmap
innovation ROADMAP • More control & monitoring applications to disability markets and beyond through miniaturisation of our technology, on the road towards the “totally wired user”. More news in Q3. • Global Medical Patient Monitoring Market $23.3B, 2020, CAGR 6.9%. Wireless segment 7.3%* • Global e
Slide 22: Contact
contact Rob Wong Brett Crowley CEO Company Secretary robwong@controlbionics.com brettcrowley@controlbionics.com +61 419238768 +61 3 9897 3576 21 Morgans Technology Conference | November 24, 2021